Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 6, 2026

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
07:51

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy

Published on: June 1, 2019

Axillary recurrence after negative sentinel lymph node biopsy.

Hee Jeong Kim1, Byung Ho Son, Eun Wha Park

  • 1Department of Surgery, University of Ulsan College of Medicine and Asan Medical Center, Songpa-Gu, Seoul, Korea.

Breast Cancer Research and Treatment
|April 5, 2008
PubMed
Summary

Sentinel lymph node biopsy (SLNB) for node-negative breast cancer showed a low axillary recurrence rate. Hormone-receptor negative status may increase risk for regional nodal failure after SLNB.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preoperative breast MRI and long-term survival in ductal carcinoma in situ: a propensity score-weighted analysis.

European radiology·2026
Same author

PAK1 expression protects cellular and behavioral defects in animal models of Parkinson' s disease.

Molecular brain·2026
Same author

Retrospective study on the magnetic resonance imaging integration rate of acellular dermal matrix and complications after breast-conserving surgery plus radiotherapy.

World journal of surgical oncology·2026
Same author

Radiation therapy management in BRCA1/2 carriers diagnosed with early breast cancer: An international cohort study.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

Tumor-Associated Macrophage Infiltration and PD-L1 Expression in Gastric Cancer According to a Modified TCGA-Based Classification.

Journal of gastric cancer·2026
Same author

Long-term prognostic implications of AI-detected versus AI-undetected breast cancers on mammography: a propensity score-matched analysis.

European radiology·2026

Area of Science:

  • Oncology
  • Surgical Oncology
  • Breast Cancer Research

Background:

  • Sentinel lymph node biopsy (SLNB) is the standard for node-negative breast cancer, replacing axillary lymph node dissection.
  • Regional nodal recurrence is a concern following SLNB due to its false-negative rates (0-22%).

Purpose of the Study:

  • To evaluate axillary recurrence rates and identify risk factors in breast cancer patients after a negative SLNB.
  • To assess long-term outcomes 40 months post-SLNB.

Main Methods:

  • Retrospective analysis of 940 node-negative breast cancer patients undergoing SLNB.
  • Focus on 720 patients with negative SLNB results, categorized by subsequent axillary treatment (dissection, sampling, or SLNB only).
  • Utilized 99mTc radiocolloid with subareolar injection for SLNB.

More Related Videos

Single-port Non-liposuction Endoscopic Axillary Lymph Node Dissection in Breast Cancer Surgery
11:49

Single-port Non-liposuction Endoscopic Axillary Lymph Node Dissection in Breast Cancer Surgery

Published on: April 3, 2026

Related Experiment Videos

Last Updated: Jul 6, 2026

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
07:51

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy

Published on: June 1, 2019

Single-port Non-liposuction Endoscopic Axillary Lymph Node Dissection in Breast Cancer Surgery
11:49

Single-port Non-liposuction Endoscopic Axillary Lymph Node Dissection in Breast Cancer Surgery

Published on: April 3, 2026

Main Results:

  • A mean of 2.1 sentinel lymph nodes (SLNs) were removed per patient.
  • At 40-month median follow-up, only three patients experienced axillary recurrence, all from the SLNB-only group.
  • Two of the three recurrent cases also showed internal mammary lymph node involvement; tumors were hormone-receptor negative and often c-erbB2 negative.

Conclusions:

  • Axillary recurrence rates are low in node-negative breast cancer patients after successful SLNB.
  • Hormone-receptor negative status and high nuclear grade are potential risk factors for regional nodal failure post-SLNB.